The European Multidisciplinary Colorectal Cancer Congress (EMCCC) is the European conference that truly provides a platform for in-depth multidisciplinary interaction among the various research areas involved. The Dutch Colorectal Cancer Group (DCCG) has taken the initiative for the EMCCC since 2001. The conference in 2016 builds upon seven previous successful multidisciplinary conferences on colorectal cancer which were held in the Netherlands, Germany and France. The EMCCC offers an intimate scientific/educational environment for 700 participants.

1. 8th
European Multidisciplinary
Colorectal Cancer Congress
General Information General Information
CME Accreditation
Accreditation is applied for at the European Accreditation Council for Continuing Medical
Education (EACCME). This accreditation will be endorsed by the European Union of Medical
Specialists (UEMS) ensuring that the CME credits awarded to the participants are recognized
by the national medical authorities who have agreed to co-operate in this European system.
EACCME credits are recognized by the American Medical Association towards the Physician’s
Recognition Award (PRA).
Venue
The congress will be held in the RAI Amsterdam, the Netherlands.
Exhibition & sponsored symposia
A targeted group of biotechnical and pharmaceutical companies will be invited to organize a
sponsored integrated symposium and or exhibit their products and services.
Language
The official congress language will be English. No simultaneous translation will be available.
Letter of invitation
The organizers will be pleased to send a letter of invitation to any individual requesting one,
once their registration form and fee have been received. It is to be understood that such an
invitation is intended to help potential participants raise travel funds or obtain a visa. It is not
a commitment on the part of the congress to provide any financial support. Applications have
to be received by the conference secretariat before 1 October 2016. A refused visa application
is no reason for refund.
Insurance
In registering for the EMCCC2016 delegates agree that neither the organization nor the congress
agency Congress Care is responsible for individual medical, travel or personal insurance.
Delegates are requested to arrange their own travel and health insurance.The organizers cannot
assume liability for changes in the program due to external circumstances.
Website
Please check de website www.emccc2016.org for more relevant information and (programme)
updates.
WWW.EMCCC2016.ORGWWW.EMCCC2016.ORG
Call for abstracts
Deadline:Thursday 1 September 2016, 10.00hrs. CET (Central EuropeanTime)
The EMCCC Scientific Committee would like to encourage authors to submit their abstracts.The
online submission module is available on the congress website.
Registration
Registration fees
Early Bird Regular Late
(until 1 July ‘16) (2 July -1 October ‘16) (as of 2 October ‘16)
Physicians &
academics EUR 475 EUR 675 EUR 795
Physicians &
academics in training EUR 295 EUR 395 EUR 495
Emerging economy rate EUR 175 EUR 200 EUR 200
What is included in the registration fee?
The registration fee for delegates includes: admission to the meeting, welcome reception,
programme and abstract book, e-certificate of attendance, 2 lunches and all coffee breaks.
Registration & payment
Registration is possible via the congress website. Payment can be done online (all regular
credit cards and SEPA direct debit).
Group registrations
For group registrations please contact the congress secretariat via: info@congresscare.com.
Group registration is available for groups of 5 participants or more.
Terms & conditions
Terms and conditions for registration and cancellation apply. Information can be found at the
congress website.
Hotel accommodation
The organisation of the 8th
European Multidisciplinary Colorectal Cancer Congress has secured a
number of rooms in several hotels located near the Congress Centre. Individual reservations can
be made using the On-line Accommodation Booking Form (www.emccc2016.org).
Abstract
Deadline:
1 Sept.
2016
11 - 13 december 2016
RAI Amsterdam, the Netherlands

2. SUNDAY 11 DECEMBER 2016
11.00 Registration
13.00 - 16.00 Workshops
Workshop 1.1 Methodology of clinical trials
Workshop 1.2 Surgical treatment of metastatic disease
Workshop 1.3 Radiotion oncology
Workshop 1.4 Pathology
Workshop 1.5 Genetics
Workshop 1.6 colon and rectal cancer imaging
16.00 - 17.30 Sponsored Symposium 1
17.45 Opening
18.00 Welcome reception
MONDAY 12 DECEMBER 2016
08.00 - 10.00 Interactive computerized radiology workshop
08.15 Session 1 Follow-up
09.30 Session 2 Health economics and Quality of care
10.45 Break
11.15 Session 3 Updated results from phase 3 trials
12.30 - 14.00 Lunch & Posters
12.45 - 13.45 Sponsored Symposium 2
14.00 Key-note lecture:
The genomic landscape of colorectal cancer
14.45 Session 4Translational research
15.15 Session 5 Controversy 1
16.00 - 16.30 Break
16.30 Session 6 Multidisciplinary management
17.45 – 19.00 Drinks & Posters
TUESDAY 13 DECEMBER 2016
08.00 - 10.00 Interactive computerized radiology workshop
08.15 Session 7 Prevention and screening
09.30 Session 8 Genetics
10.45 - 11.15 Break
11.15 Session 9 Colorectal cancer and the immune system
12.30 - 14.00 Lunch & Posters
12.45 Sponsored Symposium 3
14.00 Session 10 Rectal cancer surgery
15.15 Session 11 Controversy 2
16.00 - 16.30 Break
16.30 Session 12 Interval colorectal cancer: from nomenclature to benchmarking
17.45 Drinks
It is our great pleasure to announce the 8th
EMCCC 2016!
The European MultidisciplinaryColorectalCancerCongress (EMCCC) is the European conference that
truly provides a platform for in-depth multidisciplinary interaction among the various research areas
involved. The Dutch Colorectal Cancer Group (DCCG) has taken the initiative for the EMCCC since
2001. The conference in 2016 builds upon seven previous successful multidisciplinary conferences
on colorectal cancer which were held in the Netherlands, Germany, France and Czech Republic.
The EMCCC offers an intimate scientific/educational environment for around 700 participants.
Colorectal cancer is one of the most common types of malignancies and much progress has been
made in recent years in understanding the biology and treatment of this disease.These developments
encompass almost the full research area including genetics, biology, pathology/prognostic markers,
surgery, screening, systemic treatment, radiotherapy, and imaging.This implies that both pre-clinical
and clinical research is becoming much more multidisciplinary oriented.
The conference will have separate workshops on surgery, medical oncology, radiotherapy, pathology,
imaging, gastroenterology, and genetics, but all other sessions are plenary in order to have optimal
interaction between all disciplines. The format of the conference consists of workshops, a keynote
lecture, controversy sessions, satellite symposia, and oral and poster presentations on prevention and
screening, diagnosis and follow-up, translational research, multidisciplinary management, genetics,
evaluation of treatment, and updates on randomizedCRC trials.
Looking forward meeting you in December inAmsterdam!
The EMCCC local organising committee,
Prof.dr.C.J.A. Punt, medical oncology, congress president
Prof.dr. R.G.H. Beets-Tan, radiology
Prof.dr. N. Hoogerbrugge-van der Linden, antropogenetics
Prof.dr.C.A.M. Marijnen, radiotion oncology
Prof.dr.G.A. Meijer, pathology
Dr.S.Sanduleanu, gastroenterology
Dr. P.J.Tanis, surgery
Scientific Programme Scientific committeeIntroduction
Surgery
P.J.Tanis (the Netherlands)
E.Tiret (France, European Society of
Coloprectology)
G. Beets (the Netherlands, European Society
of Digestive Oncology)
A. Martling (Sweden, European Society of
Coloproctology)
D. Morton (United Kingdom, research
committee ESCP)
G. Romano (Italy, UEG representative ESCP)
T. Gruenberger (Austria, ESDO)
S. Biondo (Spain, ESCP)
Medical Oncology
C.J.A. Punt (the Netherlands)
D. Arnold (Germany)
A. Sobrero (Italy)
R. Adams (UK)
T. Andre (France)
M. Peeters (Belgium)
H. Sorbeye (Norway)
Radiation Oncology
D. Sebag-Montefiore (United Kingdom)
C.A.M. Marijnen (the Netherlands)
K. Haustermans (Belgium)
C. Rödel (Germany)
V.Valentini (Italy)
J.P. Gérard (France)
K. Bujko (Poland)
Gastroenterology
E. Dekker (the Netherlands)
C. Rees United Kingdom)
L. Ricciardiello (Italy)
M. Bretthauer (Norway)
Imaging
R.G.H. Beets-Tan (the Netherlands)
A. Laghi (Italy)
L. Blomqvist (Sweden)
T. Helmberger (Germany)
J. Stoker (the Netherlands)
M. Stokkel (the Netherlands)
S. Halligan (United Kingdom)
P. Flamen (Belgium)
Genetics
N. Hoogerbrugge-van der Linden (the
Netherlands)
G. Evans (United Kingdom)
M. Genuardi (Italy)
E. Holinky-Feder (Germany)
T. Frebourg (France)
R. Sijmons (the Netherlands)
M.Tischkowitz (United Kingdom)
Pathology
G. Meijer (the Netherlands)
Ph. Quirke (UK)